Sarb Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 31-05-2024
- Paid Up Capital ₹ 0.50 M
as on 31-05-2024
- Company Age 3 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2022)
- Net Worth -1.25%
(FY 2022)
- Total Assets 1852.50%
(FY 2022)
About Sarb Pharma
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Rajesh Arora, Sukhamrit Singh, Jagjit Singh, and One other member serve as directors at the Company.
- CIN/LLPIN
U24299PB2020PTC052534
- Company No.
052534
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Dec 2020
- Date of AGM
25 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Amritsar, Punjab, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sarb Pharma?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sukhamrit Singh  | Director | 30-Dec-2020 | Current |
| Rajesh Arora | Director | 30-Dec-2020 | Current |
| Jagjit Singh | Director | 30-Dec-2020 | Current |
| Ajay Kumar | Director | 30-Dec-2020 | Current |
Financial Performance and Corporate Structure Insights of Sarb Pharma.
Sarb Pharma Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth dipped by a decrease of 1.25%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Sarb Pharma?
Unlock access to Sarb Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Himalaya Land Developers And Builders Private LimitedActive 18 years 5 monthsRajesh Arora and Jagjit Singh are mutual person
- Topheaven Realtors Private LimitedActive 3 years 9 months
Rajesh Arora and Jagjit Singh are mutual person
- Estaleo Realtors Private LimitedActive 3 years 9 months
Rajesh Arora and Jagjit Singh are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sarb Pharma?
Unlock and access historical data on people associated with Sarb Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sarb Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sarb Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
